The Michigan Center for Contextual Factors in Alzheimer's Disease (MCCFAD) is the collaborative effort between University of Michigan, Michigan State University
We are excited to share that MCCFAD hosted its 4th Annual Summer Data Immersion Program (SDI) from May 22 to 25. This year's SDI focused on Neighborhood Context and Alzheimer’s Disease and Related Dementias.
The applications for the 2023 Summer Data Immersion program are now open! The program dates are May 22-25.
Interested individuals should complete the application using the following link: https://t.co/NgO36INpGQ
Applications with attached CVs should be submitted by February 13.
📢New Publication @geronsociety#JGSS@GeronMedia w colleagues from @mccfad summer data immersion program. Using @NHATS_NSOC we highlight the importance of dementia classification & age of migration for caregiver psychological well-being.#fb_heterogen
https://t.co/LapfxAQDmk
In the 2021 @mccfad summer data immersion program, we worked together to develop the Care Collaboration Index of multiple caregivers using @NHATS_NSOC. This paper is now published @GeronMedia! https://t.co/1Ku6cUL2Je
The applications for the 2023 Summer Data Immersion program are now open! The program dates are May 22-25.
Interested individuals should complete the application using the following link: https://t.co/NgO36INpGQ
Applications with attached CVs should be submitted by February 13.
MCCFAD is excited to announce the Mercedes Florez Memorial Fund, which provides funding to graduate students for research on ADRD, with a specific focus on serving the Latinx community. The application can be accessed here: https://t.co/pdqj5s9WGY. Applications are due on Jan 20.
We are excited to share that MCCFAD hosted its 3rd Annual Summer Data Immersion Program (SDI) from May 23 to 26. This year's SDI focused on the costs of Alzheimer's Disease and Related Dementias.
CARD is doing incredible work to harness #Alzheimers data for research. Check out their data resources (and don't miss their #AlzScience training opportunities, too): https://t.co/Y1Z7uPSX4B
Center Associate Director, Dr. Bruno Giordani chimes in that biomarkers and new drugs are the most exciting AD research advance in the last 10 years.
#AlzScience
A1: NINDS collaborates with @NIHAging to establish research priorities and fund biomedical research in AD as well as several Alzheimer’s disease-related dementias (ADRDs). https://t.co/5pl4vsPzjX. #AlzScience